Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Mar 8, 2007 at 3:57 AM EST

Bruker BioSciences: Earnings Growing, Insiders Buying

by H.S. AyoubBioHealth Investor.com Bruker BioSciences (BRKR) seems primed for a great performance in 2007. The maker of mass spectrometry…

Douglas A. McIntyre | Mar 8, 2007 at 3:56 AM EST

Biotech Stock Performance Around Critical Events

From World Beta In her 2001 book "From Alchemy to IPO" Cynthia Robbins Roth cites a Hambrecht & Quist study…

Douglas A. McIntyre | Mar 7, 2007 at 4:09 AM EST

Tuesday’s Top Biotech & Medical Stocks

From BioHealth Investor Biotechnology ANTIGENICS INC [AGEN] +11.46% CADENCE PHARM. INC. [CADX] +10.04% COMBINATORX [CRXX] +9.53% GENITOPE CORPORATION [GTOP] +9.24%…

Douglas A. McIntyre | Mar 6, 2007 at 4:52 PM EST

Biotech Implosion: CV Therapeutics (CVTX)

CV Therapeutics (CVTX) just showed Ranexa study for chronic chest pain (angina) that aren’t what investors were hoping for. The…

Douglas A. McIntyre | Mar 6, 2007 at 2:21 PM EST

Why UnitedHealth’s Filing Catch-Up Doesn’t Matter

UnitedHealth (UNH-NYSE) has finally become current in its SEC Filings as of this morning, but this shouldn’t be that big…

Douglas A. McIntyre | Mar 6, 2007 at 4:16 AM EST

Monday’s Top Biotech & Medical Stocks

From BioHealth Investor Biotechnology CYPRESS BIOSCIENCE [CYPB] +5.81% SGX PHARMACEUTICALS [SGXP] +5.44% AFFYMAX, INC. [AFFY] +5.35% CERAGENIX PHARMACUTL [CGXP.OB] +5.26%…

Douglas A. McIntyre | Mar 5, 2007 at 9:08 AM EST

Biotech Implosion: Memory Pharmaceuticals Corp. (MEMY)

Early this morning, Memory Pharmaceuticals (MEMY) dropped a bomb with its announcement that Phase IIa results for MEM1003 failed to…

Douglas A. McIntyre | Mar 4, 2007 at 11:40 AM EST

Friday’s Top Biotech & Medical Stocks

From BioHealth Investors Biotechnology INSMED INC [INSM] +13.87% BIODELIVERY SCI INTL [BDSI] +8.86% FAVRILLE, INC. [FVRL] +5.81% VERNALIS PLC ADR…

Douglas A. McIntyre | Mar 4, 2007 at 11:38 AM EST

IBD Weekly Top Ranked Medical Stocks

From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative…

Douglas A. McIntyre | Mar 4, 2007 at 11:37 AM EST

Thermogenesis Ups Production of Cord Blood Stem Cell Processing Bags

by H.S. AyoubBioHealth Investor.com Thermogenesis (KOOL) announced early Friday that the company has increased its manufacturing capacity for the cord…

Douglas A. McIntyre | Mar 2, 2007 at 11:55 AM EST

IPO Filing: Sirtris, A Diabetes Biotech

There has been another diabetes treatment-seeker that has filed to come public. Sirtris Pharmaceuticals has filed for an IPO and…

Douglas A. McIntyre | Mar 1, 2007 at 4:23 AM EST

BRL: Barr the Windows

By William Trent, CFA of Stock Market Beat Large Cap Watch List member Barr Pharmaceuticals (BRL) reported a GAAP Loss:…

Douglas A. McIntyre | Mar 1, 2007 at 4:07 AM EST

Wednesday’s Top Biotech & Medical Stocks

From BioHealth Investor Biotechnology PIPEX PHARMACEUTICAL [PPXP.OB] +12.90% BOSTON LIFE SCIENCES [BLSI] +10.63% INSMED INC [INSM] +7.58% CURAGEN CORP [CRGN]…

Douglas A. McIntyre | Feb 28, 2007 at 9:45 AM EST

Biotech IPO Filing: Endoceutics of Canada

A Canadian biotech company named Endoceutics, Inc. has filed with the SEC to raise up to $75 million via an…

Douglas A. McIntyre | Feb 28, 2007 at 3:45 AM EST

Tuesday’s Top Biotech & Medical Stocks

From BioHealth Investor Biotechnology CURAGEN CORP [CRGN] +12.36% REPLIDYNE, INC. [RDYN] +5.98% INSMED INC [INSM] +4.76% LPATH INC [LPTN.OB] +3.85%…

1 … 378 379 380 381 382 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Bruker BioSciences: Earnings Growing, Insiders Buying

Biotech Stock Performance Around Critical Events

Tuesday’s Top Biotech & Medical Stocks

Biotech Implosion: CV Therapeutics (CVTX)

Why UnitedHealth’s Filing Catch-Up Doesn’t Matter

Monday’s Top Biotech & Medical Stocks

Biotech Implosion: Memory Pharmaceuticals Corp. (MEMY)

Friday’s Top Biotech & Medical Stocks

IBD Weekly Top Ranked Medical Stocks

Thermogenesis Ups Production of Cord Blood Stem Cell Processing Bags

IPO Filing: Sirtris, A Diabetes Biotech

BRL: Barr the Windows

Wednesday’s Top Biotech & Medical Stocks

Biotech IPO Filing: Endoceutics of Canada

Tuesday’s Top Biotech & Medical Stocks

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Health and Healthcare Articles

All Health and Healthcare Articles

Bruker BioSciences: Earnings Growing, Insiders Buying

Biotech Stock Performance Around Critical Events

Tuesday’s Top Biotech & Medical Stocks

Biotech Implosion: CV Therapeutics (CVTX)

Why UnitedHealth’s Filing Catch-Up Doesn’t Matter

Monday’s Top Biotech & Medical Stocks

Biotech Implosion: Memory Pharmaceuticals Corp. (MEMY)

Friday’s Top Biotech & Medical Stocks

IBD Weekly Top Ranked Medical Stocks

Thermogenesis Ups Production of Cord Blood Stem Cell Processing Bags

IPO Filing: Sirtris, A Diabetes Biotech

BRL: Barr the Windows

Wednesday’s Top Biotech & Medical Stocks

Biotech IPO Filing: Endoceutics of Canada

Tuesday’s Top Biotech & Medical Stocks

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do